Instalab
logoInstalab

PTH Intact

Blood Test
The clearest read on how your body manages calcium, catching parathyroid problems that drive bone loss, kidney stones, and heart risk.
4.9 (2,962 reviews)
Tested by Quest, Access Medical or Boston Heart
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home or at 2,000+ patient service centers
Get results
Explained with clear next steps, no medical jargon

Should you take a PTH Intact test?

This test is most useful if any of these apply to you.

Worried About Your Bones
Sustained high PTH quietly pulls calcium out of bone. This test reveals whether your parathyroid activity is driving thinning bones, especially after menopause.
Managing Kidney Disease
PTH is central to kidney-related bone and vascular complications. Tracking it guides treatment and helps catch problems before fractures or calcification.
Told Your Calcium Is Borderline
Calcium alone cannot tell you why it is high or low. PTH reveals whether a parathyroid problem, vitamin D deficiency, or something else is driving it.
Past Thyroid or Parathyroid Surgery
Neck surgery can damage parathyroid glands and cause lasting low PTH. Checking it confirms whether your hormone supply is sufficient or needs support.

About PTH Intact

Your body keeps blood calcium in an extraordinarily narrow range, and parathyroid hormone is the dial that does it. When calcium drops even slightly, four small glands behind your thyroid release this hormone to pull calcium back into balance. The level in your blood reflects how hard those glands are working, which makes it one of the most informative single measurements for bone health, kidney function, and certain hormone disorders.

Most routine blood panels measure calcium but skip the hormone that controls it. That leaves a blind spot: calcium can read as normal even when your parathyroid glands are working overtime to keep it there, signaling early kidney disease, vitamin D deficiency, or a parathyroid tumor. Checking intact PTH (full-length parathyroid hormone) tells you whether the calcium number you see is being maintained easily or paid for at a hidden cost.

What This Hormone Actually Does

Your four parathyroid glands sit behind your thyroid and constantly sample blood calcium. When calcium dips, they release PTH within minutes. The hormone then acts in three places at once: it tells your kidneys to hold onto calcium and release phosphate, it signals your bones to release stored calcium when levels stay high (intermittent low-dose pulses can actually build bone, which is how the osteoporosis drug teriparatide works), and it activates vitamin D so your gut absorbs more calcium from food.

The intact PTH test measures the full 84-amino-acid active form plus some inactive protein fragments that share part of its structure. This distinction matters most in advanced kidney disease, where inactive fragments build up in the blood and can make the apparent PTH look higher than the truly active hormone level. Newer third-generation assays detect only the active form. In advanced kidney disease they produce values roughly half of the standard intact value on average, though the ratio varies widely between individuals and is much closer to intact values in people with healthy kidneys. They have not been shown to consistently improve diagnosis.

Primary Hyperparathyroidism

Primary hyperparathyroidism is the textbook reason to order this test. It is usually caused by a small benign tumor on one parathyroid gland that secretes hormone without regard to blood calcium. Calcium rises, and PTH stays high or normal when it should be suppressed. Untreated, the condition drives kidney stones, declining kidney function, bone loss, and fractures.

Modern intact PTH assays detect this disease in over 90 percent of cases. The diagnosis hinges on a pattern, not a single number: high or upper-range calcium with PTH that is not suppressed. A reading inside the lab reference range when calcium is elevated is itself abnormal, and many cases get missed when calcium is checked alone. Surgery to remove the affected gland normalizes calcium in roughly 95 percent of properly diagnosed cases, with some series reporting cure rates as high as 99 percent.

Kidney Disease and Secondary Hyperparathyroidism

As kidney function declines, your kidneys lose the ability to clear phosphate and activate vitamin D. Both changes push PTH up. The response is at first protective, but in advanced kidney disease the glands can become permanently overactive, leading to high-turnover bone disease, fractures, and calcium deposits in blood vessels. PTH can start to creep up once filtration drops below about 60 milliliters per minute, and rises sharply in advanced kidney disease, partly from inactive fragments that the failing kidney can no longer clear.

Treatment of kidney disease often centers on bringing PTH back toward a healthier range using vitamin D analogs, phosphate binders, or calcium-sensing drugs. A falling PTH in response to treatment is associated with fewer fractures over time, especially fewer hip fractures.

Bone Loss and Fracture Risk

Sustained high PTH pulls calcium out of bone faster than your body can rebuild it. In a large study of dialysis patients, each doubling of intact PTH was associated with a meaningfully higher risk of fracture, with a stronger effect on hip fractures. The relationship is most striking in kidney disease, but the same biology applies more subtly in earlier stages. A high-normal PTH driven by vitamin D deficiency or low calcium intake can quietly accelerate bone thinning, particularly after menopause.

Cardiovascular Risk

Several large studies tie higher PTH to worse heart outcomes, though the relationship is more visible in higher-risk groups than in the general population.

Who Was StudiedWhat Was ComparedWhat They Found
About 1,000 older Swedish men, followed nearly 10 yearsEach step up in PTHHigher cardiovascular death risk after adjustment for calcium, vitamin D, and kidney function
About 3,200 adults undergoing coronary angiography, followed about 8 yearsHighest vs lowest PTH quartileRoughly doubled all-cause mortality and cardiovascular mortality, with a stronger increase in sudden cardiac death
About 8,000 European hemodialysis patientsLowest and highest PTH ranges vs middleHigher mortality at both the low and high ends (U-shaped pattern)

Sources: ULSAM cohort; LURIC study; ARO Europe hemodialysis cohort. What this means for you: a high-normal or elevated PTH carries the most prognostic weight when other heart risk factors are already present. In community cohorts of generally healthy people, the link to coronary disease is weak or inconsistent in pooled analyses, so PTH is best read alongside your broader cardiovascular picture rather than in isolation.

Low PTH and Hypoparathyroidism

Low PTH usually means the parathyroid glands have been damaged, removed during thyroid surgery, or attacked by your immune system. Without enough hormone, calcium falls and phosphate rises. The result is muscle cramping, tingling, fatigue, and in severe cases seizures or calcium deposits in the brain. About three quarters of cases follow anterior neck surgery. The harder ones to catch are subtle: PTH sitting at the bottom of the reference range with borderline-low calcium. A single test paired with calcium answers this question definitively.

Why the U-Shape Is Not a Contradiction

In kidney disease, both very high and very low PTH are linked to higher death rates. At first glance this seems contradictory: if high PTH causes bone loss, shouldn't lower always be better? PTH is a controller, not a poison. Too much causes high-turnover bone disease and vascular calcification. Too little causes adynamic bone disease, where bone stops remodeling and becomes brittle in a different way. The marker tracks parathyroid activity in both directions, and the clinical goal is balance, not minimum.

When Results Can Be Misleading

  • Time of day: PTH peaks between 2 and 4 a.m. and falls by morning. For consistency, draw blood at the same time of day each test.
  • Kidney function: As kidney filtration falls, inactive PTH fragments accumulate. Standard intact assays detect these fragments, which can inflate the apparent PTH by close to half in advanced kidney disease.
  • Recent neck surgery: After thyroid or parathyroid surgery, PTH can fluctuate dramatically for weeks, including a rebound rise weeks to months later that does not indicate recurrent disease.
  • Assay differences: Commercial intact PTH assays can produce results that differ substantially on the same sample. Comparing values across labs is unreliable. Vitamin D status, season, body weight, smoking, and inflammation can all shift the result independently of true parathyroid activity.

Why One Reading Is Not Enough

Intact PTH has notable within-person biological variability over a few weeks. Studies suggest a change of roughly 70 percent between two readings is needed before you can be confident the difference is real rather than noise. Smaller fluctuations usually reflect normal variation, not true change.

Establish a baseline, then retest in 3 to 6 months if you are making changes (vitamin D repletion, calcium intake, kidney treatment, parathyroid follow-up). Once stable, retest at least annually. Always use the same lab and the same assay platform. Track PTH alongside calcium, phosphate, vitamin D, and kidney function rather than as an isolated number.

What to Do With an Out-of-Pattern Result

If your PTH is high, the next questions are: where is your calcium, where is your vitamin D, and how are your kidneys filtering? High PTH with high calcium points toward primary hyperparathyroidism and warrants an endocrinologist or experienced parathyroid surgeon. High PTH with low or normal calcium plus low vitamin D usually responds to vitamin D correction first. High PTH with declining kidney function calls for a nephrologist and a workup of phosphate, calcium, and bone health.

If your PTH is low, the immediate companion is calcium. Low PTH with low calcium suggests hypoparathyroidism and warrants endocrinology referral. In any pattern, repeat testing on the same assay confirms that the result is real rather than noise. Pair PTH with a bone density scan if there is any concern for high or low bone turnover, and with a 24-hour urine calcium if kidney stones are part of the picture.

What Moves This Biomarker

Evidence-backed interventions that affect your PTH Intact level

↓ Decrease
Parathyroidectomy (surgical removal of an overactive parathyroid gland)
Removing the overactive gland causes a rapid, large drop in intact PTH within minutes and normalizes calcium in roughly 95 percent of patients with primary hyperparathyroidism, with some series reporting cure rates as high as 99 percent. This is the definitive treatment when surgery is appropriate, and intraoperative PTH measurement confirms cure when the hormone falls 50 percent or more within about 10 to 15 minutes after gland removal.
MedicationStrong Evidence
↓ Decrease
Calcium-sensing receptor drugs (cinacalcet, etelcalcetide) for kidney disease
These drugs make parathyroid cells more sensitive to calcium, dialing down hormone release. In dialysis patients, a majority achieve a meaningful PTH reduction over several months of treatment, compared with a small minority on placebo. Etelcalcetide is given by IV three times a week; cinacalcet is daily oral. Both lower fracture risk and may reduce mortality over years of use.
MedicationStrong Evidence
↓ Decrease
Active vitamin D analogs (paricalcitol, calcitriol) for kidney disease
These act on vitamin D receptors in parathyroid cells, suppressing hormone production. In hemodialysis patients, intravenous paricalcitol over 12 weeks produced roughly a 50 percent decrease in mean intact PTH, with a large majority achieving at least a 30 percent reduction versus a small minority on placebo. Standard care for secondary hyperparathyroidism in advanced kidney disease.
MedicationStrong Evidence
↓ Decrease
Kidney transplantation for end-stage kidney disease
Restoring kidney function rapidly improves phosphate clearance and vitamin D activation, allowing PTH to fall in the first 3 months after transplant. However, a large majority of recipients still have elevated PTH at 12 months without specific treatment, reflecting parathyroid gland hyperplasia that takes longer to resolve. Persistent post-transplant high PTH may need its own therapy.
MedicationStrong Evidence
↑ Increase
PTH replacement therapy (recombinant PTH 1-84) for hypoparathyroidism
In hypoparathyroidism, the goal is to raise the missing hormone toward normal levels and restore proper calcium and bone signaling. Daily subcutaneous PTH for 24 weeks allowed patients to substantially reduce their calcium and active vitamin D doses while maintaining normal blood calcium. Restores more physiologic bone turnover than calcium and vitamin D alone.
MedicationStrong Evidence
↓ Decrease
Native vitamin D (cholecalciferol) when vitamin D is deficient
Correcting vitamin D deficiency removes a major stimulus for PTH release. In kidney transplant recipients with deficiency, daily cholecalciferol over about a year modestly reduced PTH compared with placebo and contributed to better preservation of spine bone density. Effect is largest when starting from clear deficiency; mild insufficiency may not produce a visible PTH drop unless calcium intake is also adequate.
SupplementModerate Evidence
↓ Decrease
Adequate calcium intake (about 1,000 mg/day from diet or supplements when low)
Chronically low dietary calcium drives ongoing low-grade PTH elevation as the glands work to maintain blood calcium. Restoring adequate intake reduces this stimulus. In bariatric surgery patients given combined vitamin D, about 1,000 mg/day calcium, protein, and structured exercise over two years, PTH fell more than twice as much as in usual care.
DietModerate Evidence
↑ Increase
Loop diuretics (furosemide and similar) used long-term
Loop diuretics cause your kidneys to excrete extra calcium in urine. The ongoing calcium loss drives a real, mild secondary increase in PTH as the glands compensate to defend blood calcium. This is a true biological elevation, not a lab artifact, and over time can contribute to bone loss. Worth knowing if you are on these drugs long-term and your PTH reads high.
MedicationModest Evidence

Frequently Asked Questions

References

20 studies
  1. Silverberg S, Gao P, Brown I, Logerfo P, Cantor T, Bilezikian JThe Journal of Clinical Endocrinology and Metabolism2003
  2. Sprague S, Bellorin-font E, Jorgetti V, Carvalho a, Malluche H, Ferreira a, D'haese P, Drueke T, Du H, Manley T, Rojas E, Moe SAmerican Journal of Kidney Diseases2016
  3. Inaba M, Okuno S, Imanishi Y, Ueda M, Yamakawa T, Ishimura E, Nishizawa YOsteoporosis International2005